# Efficacy and Tolerability of Test Product Versus Cysteamine 5% in Treatment of Facial Epidermal Melasma

> **NCT06278948** · NA · UNKNOWN · sponsor: **Cosmetique Active International** · enrollment: 140 (estimated)

## Conditions studied

- Melasma

## Interventions

- **OTHER:** Group TP
- **DRUG:** Group CYS

## Key facts

- **NCT ID:** NCT06278948
- **Lead sponsor:** Cosmetique Active International
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-06
- **Primary completion:** 2024-06
- **Final completion:** 2024-06
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2024-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06278948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06278948, "Efficacy and Tolerability of Test Product Versus Cysteamine 5% in Treatment of Facial Epidermal Melasma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06278948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*